Home -> Law Blog Directory -> Personal Injury Law Blogs -> Bodily Injury Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Bodily Injury BlogCancer Drug May Be Condemned By F.D.A.
By Edward Bills
The F.D.A. is considering the rare move of revoking their approval of the breast cancer drug Avastin because the benefits of the drug may not outweigh the risks. Medical experts made a recommendation to the F.D.A. earlier this year condemning the drug due to its potential toxic side effects and extremely high cost. Recent studies show Avastin does not prolong a users’ life for any considerable amount of time. Experts say Avastin has drastic side effects, including “blood clots, bleeding, and heart failure.”
Full post as published by Bodily Injury Blog on August 16, 2010 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Pittsburgh Cancer Center
Wanrs of Cell Phone and Cancer Risk
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Condemned Redevelopment
City of Baltimore agrees to $7.8 million property use dispute settlement with Warner Street Inc.
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters
Breast Cancer Patient Awarded $8.1 Million in Discrimination Case
Breast Cancer Patient Awarded $8.1 Million in Discrimination Case
Digitek Recalled
the heart drug allegedly contains double the medication that it should

Pfizer to Withdraw Cancer Drug Mylotarg
Amgens experimental cancer drug has minimal effect on brain cancer
Panel: Avastin Shouldn't Be Used for Breast Cancer
Cancer patient with months to live wins court order for last-chance drug on NHS
Drug giant disputes studies linking drug to increased cancer risk
Thailand Avoids Compulsory Licence On Cancer Drug; 3 More Drugs Undecided








